B Martin, E Golden, OD Carlson, P Pistell, … - Diabetes, 2009 - Am Diabetes Assoc OBJECTIVE—The aim of this study was to find an effective treatment for the
genetic form of diabetes that is present in some Huntington's disease patients
and in Huntington's disease mouse models. Huntington's disease is a ... Cited by 7 - Related articles - All 4 versions
- ►nursing2008.com J Phan, MA Hickey, P Zhang, MF Chesselet, … - Human Molecular Genetics, 2009 - Oxford Univ Press In addition to the hallmark neurological manifestations of Huntington's disease
(HD), weight loss with metabolic dysfunction is often observed in the later
stages of disease progression and is associated with poor prognosis. The ... Cited by 6 - Related articles - All 6 versions
M Markianos, M Panas, N Kalfakis, D … - Neuro endocrinology letters, 2007 - ncbi.nlm.nih.gov OBJECTIVE: The neuronal loss in several brain regions that characterize the
progression of Huntington's disease (HD), is expected to influence the
activities of hypothalamus-adrenal and hypothalamus-gonadal axes, and the ... Cited by 5 - Related articles - All 2 versions
Å Petersén, S Hult, D Kirik - Neurodegenerative Dis, 2009 - content.karger.com Huntington's disease (HD) is a neurodegenerative disorder caused by an expanded
CAG repeat in the huntingtin gene. Although it is characterized by progressive
motor impairments, cognitive changes and psychiatric disturbances are major ... Cited by 1 - Related articles - All 3 versions
A Aziz, R Fronczek, M Maat-Schieman, U … - Brain Pathol, 2008 - interscience.wiley.com To evaluate whether hypocretin-1 (orexin-A) and melanin-concentrating hormone
(MCH) neurotransmission are affected in patients with Huntington disease (HD),
we immunohistochemically stained hypocretin and MCH neurons and estimated ... Cited by 10 - Related articles - All 5 versions
J Fahrenkrug, N Popovic, B Georg, P Brundin, … - Journal of Molecular Neuroscience, 2007 - neuronalsurvival.se Page 1. 1 Decreased VIP and VPAC2 receptor expression in the biological
clock of the R6/2 Huntington disease mouse. Jan Fahrenkrug1 ... Cited by 6 - Related articles - View as HTML - BL Direct - All 5 versions
K Bacos, M Björkqvist, Å Petersén, L Luts … - Histochemistry and Cell Biology, 2008 - Springer Histochem Cell Biol (2008) 129:623–629 DOI 10.1007/s00418-008-0393-z ...
Islet -cell area and hormone expression are unaltered ... Karl Bacos · Maria
Björkqvist · Åsa Petersén · Lena Luts · Marion LC Maat-Schieman · ... Cited by 6 - Related articles - BL Direct - All 4 versions
N Saleh, S Moutereau, A Durr, P Krystkowiak, … - PLoS ONE, 2009 - pubmedcentral.nih.gov Conceived and designed the experiments: NS PM. Analyzed the data: NS.
Contributed reagents/materials/analysis tools: NS. Wrote the paper: NS.
Participated in the interpretation of the study and of the final paper and ... Cited by 2 - Related articles - All 6 versions
NA Aziz, MA van der Marck, H Pijl, MGM Olde … - Journal of Neurology, 2008 - Springer Neurodegenerative disorders are traditionally associ- ated with
cognitive,psychiatric and motor impairments. However,what is much less
appreciated is that the course of many neurodegenerative disorders can also ... Cited by 2 - Related articles - All 5 versions
